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Abstract
The emergence of multidrug-resistant (MDR) typhoid is a major global health threat affecting 
many countries where the disease is endemic. Here whole-genome sequence analysis of 1,832 
Salmonella enterica serovar Typhi (S. Typhi) identifies a single dominant MDR lineage, H58, that 
has emerged and spread throughout Asia and Africa over the last 30 years. Our analysis identifies 
numerous transmissions of H58, including multiple transfers from Asia to Africa and an ongoing, 
unrecognized MDR epidemic within Africa itself. Notably, our analysis indicates that H58 
lineages are displacing antibiotic-sensitive isolates, transforming the global population structure of 
this pathogen. H58 isolates can harbor a complex MDR element residing either on transmissible 
IncHI1 plasmids or within multiple chromosomal integration sites. We also identify new mutations 
that define the H58 lineage. This phylogeographical analysis provides a framework to facilitate 
global management of MDR typhoid and is applicable to similar MDR lineages emerging in other 
bacterial species.
S. Typhi, the primary global cause of human typhoid (enteric fever), is a monophyletic 
serovar of S. enterica. Unlike many Salmonella, S. Typhi are highly restricted to infection of 
humans and are associated with systemic infection, prolonged fever and an asymptomatic 
carrier state1. Typhoid is still a common disease in many regions of the world with poor 
infrastructure and limited economic development and is also a risk for travelers who visit 
such regions2. It is estimated that 20–30 million cases of typhoid occur annually, although 
deaths are less frequently reported than before the availability of effective antimicrobials3,4.
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In addition to improvements in access to clean water and sanitation, typhoid can potentially 
be controlled by other interventions such as vaccination5–7 and antimicrobial therapy8. 
Chloramphenicol, ampicillin and trimethoprim-sulfamethoxazole were traditional first-line 
drugs commonly used to treat acute typhoid, and these agents continue to be used in areas of 
the world where S. Typhi are deemed susceptible. However, since the 1970s, S. Typhi have 
emerged that display multidrug resistance, defined as resistance to the above antimicrobials, 
compromising treatment9–11. Since the 1990s, alternative treatment options have included 
fluoroquinolones, third-generation cephalosporins (such as ceftriaxone) and the azalide 
azithromycin1. The early emergence of MDR S. Typhi was driven in large part by the 
acquisition of IncHI1 plasmids carrying antibiotic resistance genes12 and, more recently, by 
chromosomal mutations associated with resistance to fluoroquinolones, and MDR strains 
have been reported across Asia and Africa13–16.
Phylogenetic analysis, initially based on subgenomic DNA sequences but later on whole-
genome DNA sequences, showed that the global S. Typhi population is highly clonal and 
likely originated from a common ancestor that moved into the human population several 
thousand years ago17–19. It also indicated that the population is relatively small and that 
recombination between S. Typhi and other Salmonellae is rare12,19,20. Simple SNP-based 
typing schemes have been developed that stratify the S. Typhi population into haplotypes, 
and these schemes are now used to unequivocally map new isolates to the 
phylogeny17,19,21,22. Notably, this approach identified a single emerging, highly clonal 
MDR haplotype of S. Typhi, H58, which is being reported with increasing frequency from 
many countries in Africa and Asia12,17,19,23. Within the H58 lineage, IncHI1 MDR plasmids 
of the restricted subtype PST6 (ref. 23) and chromosomal point mutations conferring 
quinolone resistance are common14,24–26. However, relatively little is known about the 
emergence and evolutionary history of the H58 lineage or how it is moving across endemic 
regions. Here we have used phylogenetic analysis based on the whole-genome sequences of 
a global collection of S. Typhi from 63 countries to investigate the genomic architecture of 
this highly successful S. Typhi lineage.
 RESULTS
 Phylogeography of H58
Of a global collection of 1,832 sequenced S. Typhi (listed in Supplementary Tables 1 and 
2), 853 (47%) belonged to haplotype H58, initially defined by the SNP glpA-C1047T 
(position 2,348,902 in S. Typhi CT18, BiP33 in ref. 17). The earliest H58 isolates in our 
collection were from 1992 (Fiji) and 1993 (Fiji and Vietnam), and H58 isolates were 
represented every year from 1992 to 2013, at a mean rate of 40% per year (Fig. 1a). H58 
isolates formed a tight cluster within the whole-genome maximum-likelihood phylogeny 
(Fig. 1b), forming a unique lineage separated by 151 SNPs from the nearest neighboring 
non-H58 cluster, which consisted exclusively of isolates from Fiji (n = 140) and Tonga (n = 
2). Individual H58 isolates differed from the most recent common ancestor (MRCA) of the 
H58 lineage by a median of just two SNPs, and the median distance between pairs of H58 
isolates was six SNPs, strongly indicative of recent clonal expansion. Nearly all of the H58 
isolates (93%; 797/853) had ≤5 isolate-specific SNPs, consistent with frequent transmission 
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relative to substitution mutations. This finding was in contrast to that for the rest of the S. 
Typhi tree, which included a wide diversity of isolates (Fig. 1b), among which only 66% 
(642/979) had ≤5 isolate-specific SNPs (P < 0.0001, Fisher’s exact test) (Supplementary 
Fig. 1).
The population structure within H58 was consistent with our previous work defining two 
major sublineages of H58 (I and II)22,25,27 but provided much greater resolution of 
substructure with a strong phylogeographical signal (Fig. 2). Our H58 S. Typhi isolates were 
collected from 21 countries across Asia, Africa and Oceania. We observed strong 
phylogeographical clustering within 13 countries (Fig. 2), indicating transmission of H58 
within these locations. Although our sample spans distinct time periods in different 
locations, in most cases, the localized subclades were isolated from the same country over 
≥4 years, indicating the establishment of long-term local reservoirs (Fig. 3a,b).
These data demonstrate that H58 is now widely disseminated across distinct geographical 
areas, and the phylogeny provides several insights into the spatial patterns of its spread. 
There were numerous instances of very closely related isolates from different countries (Fig. 
2), which indicate likely transfer events or regional outbreaks and identify routes for 
geographical dissemination (Fig. 3a,b). Maximum-likelihood analysis of inter-region 
transfers based on the maximum-likelihood phylogeny and locations where isolates were 
collected highlighted several candidate intercontinental transfers (Fig. 4). These data suggest 
that South Asia was an early hub for H58, from which it was propagated to many locations 
around the world, including countries in Southeast Asia, western Asia and East Africa, as 
well as Fiji (Figs. 2–4). Most of the diversity in lineage II was present among Indian isolates, 
with unique local subclusters detected in neighboring countries (Nepal and Pakistan) and in 
Africa, indicative of occasional transfers out of Asia. In contrast, lineage I was associated 
mainly with Southeast Asia (Vietnam, Cambodia and Laos), with evidence of transmission 
to Thailand, Pakistan, Fiji and Africa.
There have been sporadic reports of the emergence of S. Typhi in Africa14,28–30. Indeed, 
H58 isolates were predominant among the eastern and southern African S. Typhi isolates 
(63%) (Supplementary Fig. 2); in contrast, the H58 lineage was relatively rare in northern, 
western and central Africa. H58 lineages I and II were detected in Kenya, Tanzania, Malawi 
and South Africa, providing compelling evidence for multiple introductions of H58 S. Typhi 
from South Asia into the continent (Figs. 2–4). In addition, we uncovered evidence of an 
unreported recent wave of transmission of H58, based on 138 isolates, from Kenya to 
Tanzania and on to Malawi and South Africa (Figs. 2 and 3). These isolates differed from 
one another by an average of 10 (range of 0–30) SNPs, consistent with a recent clonal 
expansion. Therefore, this analysis demonstrates an ongoing epidemic of H58 typhoid across 
countries in eastern and southern Africa.
 Dating the emergence of H58
Estimating mutation rates and divergence dates within the S. Typhi population has been 
challenging, as S. Typhi is known to establish persistent asymptomatic carriage, during 
which time it likely evolves at a different rate than during acute infection, disrupting the 
molecular clock17. Here a temporal signal was barely detectable across the full S. Typhi 
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maximum-likelihood tree, assessed via linear regression of root-to-tip branch lengths on the 
basis of year of isolation (correlation coefficient (R) = 0.09 (95% confidence interval (CI) = 
0.04–0.13); P = 0.0002, Fisher’s exact test). However, a moderate signal was evident within 
the H58 subtree (R = 0.60 (95% CI = 0.56–0.64); P < 1 × 10−6, Fisher’s exact test; 
Supplementary Fig. 2). This temporal signal was entirely destroyed by randomization of 
isolation dates (mean R = 0.01), indicating that uneven sampling of the H58 lineage across 
space and time was not solely responsible for the observed association. We propose that a 
temporal signal was detectable within the H58 tree because these data capture epidemic 
spread over a relatively short time span (2–3 decades), whereas the wider S. Typhi tree 
represents much more variable population dynamics over thousands of years of evolution, 
including recent periods of endemic transmission, that differ greatly from the clonal 
expansion of H58.
We therefore proceeded to estimate the divergence date of the H58 lineage via Bayesian 
phylodemographical modeling of the H58 population, implemented in Bayesian 
Evolutionary Analysis Sampling Trees (BEAST)31. To limit potential bias due to highly 
variable sampling intensities in different geographical locations, we performed BEAST 
analyses on several cross-sections of 114 H58 isolates (13% of the total), each sampled from 
21 countries and spanning the years 1992 to 2013. The combined estimate for the median 
substitution rate within the H58 population was 1.42 × 10−7 substitutions per site per year 
(95% highest posterior density (HPD) = 1.0 × 10−7 to 1.8 × 10−7), equivalent to the 
accumulation of 0.63 SNPs per genome per year (95% HPD = 0.59 to 0.67). The analyses 
predicted that the MRCA of all extant H58 strains existed ~25 years ago (median calendar 
year for divergence, 1989; 95% HPD = 1985–1992) and that the effective population size of 
H58 increased dramatically after 1993 (Supplementary Fig. 2). Although the BEAST 
analysis was limited because of the moderate strength of the temporal signal, these results 
are consistent with the very low numbers of SNPs within the H58 lineage, the clear evidence 
of clonal expansion from the maximum-likelihood tree (Figs. 1b and 3a,b) and 
epidemiological data reporting increasing rates of multidrug resistance in Asia in the early 
1990s (refs. 13,32).
 Multidrug resistance in H58
The H58 lineage is associated with high levels of multidrug resistance and reduced 
susceptibility to fluoroquinolones12,14,25. Acquired resistance genes were identified in 671 
of the 1,832 S. Typhi isolates, including 68% of the H58 isolates in comparison to just 9% of 
non-H58 isolates (P < 1 × 10−16, Fisher’s exact test). In our collection, which included 15 
countries with ≥2 MDR isolates, H58 was significantly associated (P < 0.01) with multidrug 
resistance in nearly all these locations, with the exception of central and western Africa, 
where multidrug resistance was detected but H58 was not (Supplementary Fig. 3). The 
most common resistance genes detected were blaTEM-1 (ampicillin resistance), dfrA7, sul1 
and sul2 (resistance to trimethoprim and sulfonamides, respectively, and to trimethoprim-
sulfamethoxazole collectively), catA1 (chloramphenicol resistance) and strAB (streptomycin 
resistance). These genes were each found in >540 H58 isolates, including in 525 isolates that 
carried all 7 genes. These genes are encoded within a Tn2670-like complex transposable 
element comprising transposon Tn6029, which carries blaTEM-1, strAB and sul2, inserted 
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into transposon Tn2670, which itself comprises Tn21 carrying a class I integron (including 
sul1, with dfrA7 in the gene cassette) inserted into Tn9 carrying catA1 (refs. 12,33) (Fig. 5). 
In addition, 405 H58 isolates harbored the tetB gene located in Tn10. Other acquired 
resistance genes were rare, identified in <1% of the H58 isolates.
Previous reports linked multidrug resistance in H58 S. Typhi to the Tn2670-like element 
described above encoded on IncHI1 plasmids of the PST6 genotype12,23. Here we identified 
IncHI1-PST6 plasmids in 74% of the H58 isolates harboring the MDR element, including 
isolates from Southeast Asia, East Africa and South Asia (Supplementary Table 3), 
indicating intercontinental transmission of the IncHI1-PST6 MDR plasmid with its H58 S. 
Typhi host (Fig. 6). However, the remaining MDR H58 isolates lacked IncHI1 plasmid 
sequences, indicating that the resistance-conferring genes must be located elsewhere in the 
genomes of these 139 isolates. We screened all H58 isolates for known plasmid replicons 
and identified non-IncHI1 MDR plasmids in 23 isolates but not among isolates carrying the 
Tn2670-like MDR element (Supplementary Table 3).
Nearly all H58 isolates carried a copy of insertion sequence IS1 between the chromosomal 
genes STY3618 and STY3619, near cyaA (Fig. 6). We propose that this insertion was 
acquired early in the H58 lineage, originating from the IncHI1-PST6 plasmid. Consistent 
with this hypothesis is the present analysis showing that IS1 was absent from only a few 
isolates that were basal in the tree (Fig. 6). Long-read sequencing of 2012 Indian isolate 
ERL12960 (Supplementary Table 4) confirmed that the entire MDR locus, flanked by 
copies of IS1, was integrated at this location near cyaA (Fig. 5), in agreement with other 
recent reports15,16. The nucleotide sequence was identical to that in the IncHI1-PST6 
plasmid of H58 isolate 10425_1_48_Viety3-193_1997, which we also sequenced for 
comparison. Further in silico analysis of our data identified new insertion sequences in MDR 
isolates that lacked the IncHI1 plasmid, including (i) 25 phylogenetically related isolates 
(mostly from Bangladesh, Pakistan and Iraq) with IS1 in the yidA gene, (ii) 9 related isolates 
from Fiji with IS1 in STY4438 and (iii) 1 isolate from India with IS1 in the fbp gene (Fig. 
6). Long-read sequencing of the 2012 isolate 12148 from India confirmed integration of the 
MDR locus in the yidA gene (Fig. 5); we confirmed integration at the other two sites by 
PCR. The distribution of isolates in the H58 tree indicates single integration events at each 
of the yidA, STY4438 and fbp loci but numerous independent integrations at the cyaA site 
(Fig. 6). The latter suggests that the Tn2670-like element, which is flanked by IS1 
sequences, may target existing IS1 sequences during its mobilization.
In addition, we found that four isolates harbored genes associated with azithromycin 
resistance. These isolates were 10593_2_14_Alg05-8683_2005 from Algeria carrying ereA 
and three isolates from Indonesia carrying either msrA (10349_1_90_Indo404ty_1983) or 
msrD (9953_5_22_IndoA340_2010 and 9953_5_48_IndoA377_2010).
 Quinolone resistance in H58
The primary targets of the fluoroquinolones are the DNA gyrase subunits (gyrA and gyrB) 
and the topoisomerase IV components (parC and parE)34. Nonsynonymous mutations in the 
quinolone resistance–determining regions (QRDR) of each gene can decrease susceptibility 
to fluoroquinolones such as ciprofloxacin, which is commonly used in the treatment of 
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typhoid35. Here we found that nonsynonymous changes in the QRDR of these four genes 
were far more common in the H58 isolates (59%) than in other S. Typhi (13%; P < 1 × 10−6, 
Fisher’s exact test; Supplementary Table 5). The most frequent QRDR mutations were 
changes in codon 83 of gyrA encoding p.Ser83Phe (45% of H58 isolates) and p.Ser83Tyr 
(9% of H58 isolates) substitutions (Supplementary Table 5). The distribution of gyrA 
substitutions within the H58 phylogeny indicates that these mutations have arisen 
independently on multiple occasions, consistent with our previous observations of 
convergent evolution17,19 and confirming that this region of gyrA is under strong positive 
selection (Supplementary Fig. 4). The accumulation of multiple mutations within the gyr 
and par genes can result in a higher minimum inhibitory concentration (MIC) for 
fluoroquinolones35. Additionally, we detected multiple mutations in these genes in 199 
isolates: 190 H58 isolates (predominantly from Cambodia and India) and 9 non-H58 isolates 
(mainly from India) (Supplementary Fig. 4 and Supplementary Table 5).
Transmissible fluoroquinolone resistance can occur in Salmonella via plasmid-mediated 
acquisition of qnr genes36. Here we identified such genes in seven H58 isolates, which 
carried both gyrA mutations and the qnrS1 gene that confer high-level resistance. The qnrS1 
gene was present within a mobile element also containing blaTEM-1, sul2 and catB4, in 
association with and possibly mobilized by IS26, on an IncFIB(K) plasmid (Fig. 6 and 
Supplementary Table 3).
 Trends in antimicrobial resistance in H58
The data show some geographical differences in patterns of antimicrobial resistance within 
the H58 lineage (Supplementary Fig. 5). Multidrug resistance was common among H58 
isolates from Southeast Asia in the 1990s, and in recent years gyrA mutations have arisen on 
this background, resulting in high rates of MDR H58 with reduced susceptibility to 
fluoroquinolones. This observation likely reflects the therapeutic use of fluoroquinolones to 
treat typhoid over this period. Although we have few examples of H58 isolates from South 
Asia before 2000, the pattern is clearly different in this region, with the majority of isolates 
from recent years almost all harboring gyrA mutations but with low rates of multidrug 
resistance35. The situation appears to be different yet again in Africa, where the majority of 
recent isolates (mainly from Malawi, Kenya and South Africa) were identified as MDR but 
without gyrA mutations, potentially reflecting the continued use of traditional antimicrobial 
agents.
 Genomic signatures of the H58 lineage
Because the S. Typhi H58 lineage emerged rapidly over the past 30 years, we searched for 
any distinctive genetic signatures, other than those for multidrug resistance, that might be 
facilitating its dissemination. Prophage-like elements are known hotspots for variation 
within S. Typhi and other S. enterica37; however, H58 genomes shared five of the seven 
prophage-like elements previously identified in the S. Typhi reference isolate CT18 
(haplotype H1), and only rare acquisitions of new phages were found (five phages, affecting 
10% of the H58 isolates; Supplementary Fig. 6 and Supplementary Table 6). The SNPs 
that define the H58 lineage include several nonsynonymous changes in genes associated 
with pathogenicity, adaptation and chaperones (Supplementary Table 7). The affected 
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genes consist of ssaP, encoding a Salmonella pathogenicity island–2 (SPI-2)-associated 
protein involved in intracellular survival and persistence38, and the regulatory genes sirA and 
csrB, which have been implicated in Salmonella virulence39,40. Additionally, H58-associated 
SNPs also included changes in genes involved in central or intermediary metabolism, 
including trpE, rlpB, betC, rtn, metH, yfbT, pub, nuoG and iaaA, and genes involved in 
membranes or structures, for example, lip1, yhdA, kefA, kcsA, yegT, lsrC, yajI and 
SBOV18161 (hyaE)41. All S. Typhi display substantial genome degradation, via the 
accumulation of deletions and inactivating mutations within coding sequences, to form 
pseudogenes; each S. Typhi genome has >200 pseudogenes, reflecting a loss of ~4% of 
protein-coding capacity19,20. Here we found that all H58 isolates additionally harbored a 
point mutation in the sptP gene (STY3001) resulting in a premature stop codon at position 
185, effectively rendering H58 strains deficient for SptP protein. SptP is an SPI-1 effector 
protein known to have a role in modulating the host cell actin cytoskeleton via its GAP 
domain that targets CDC42 and RAC-1 (ref. 42). We previously identified this nonsense 
mutation in seven sequenced H58 isolates and a second distinct nonsense mutation in the 
same gene in the H50 isolate E98-3139. Convergent loss-of-function mutations such as this 
are quite rare in S. Typhi and may reflect a selective advantage for inactivation of this 
gene20.
 DISCUSSION
Here, we provide the first comprehensive global phylogeographical analysis of the emerging 
MDR-associated S. Typhi clade known as H58, covering many of the key geographical 
regions where typhoid remains endemic. This analysis indicates a major ongoing clonal 
replacement of resident non-H58 S. Typhi haplotypes by this clade and identifies previously 
unappreciated inter- and intracontinental transmission events. Smaller regional studies 
performed in different Asian countries and in Kenya have described the emergence of the 
H58 haplotype at local and country levels12,14,15,17,19,25. However, here we show the true 
global impact of H58, which is transforming the S. Typhi population structure across the 
world. Indeed, we show definitively that H58 has expanded dramatically since the early 
1990s and that the MDR phenotype of H58 strains is likely influenced by different regional 
antibiotic usage11. Further, our analyses show an ongoing epidemic of MDR typhoid moving 
across Africa, potentially driven by this antimicrobial usage. The existence of this epidemic 
is supported by the available epidemiological data, which include increasing numbers of 
reports of MDR typhoid in Africa, and by observations from members of this 
consortium14,28–30.
The H58 lineage has previously been associated with multidrug resistance, which may be a 
key factor driving its current expansion14,25. Here we show that this association holds across 
numerous countries in Asia and Africa, such that the majority of the global burden of MDR 
typhoid can be attributed to the H58 lineage. Intriguingly, our data indicate that multidrug 
resistance in H58 is tightly linked to the presence of a single Tn2670-like element that was 
probably first introduced via the IncHI1-PST6 plasmid but has since transferred to the S. 
Typhi chromosome in numerous distinct integration events, each affecting different 
sublineages of H58. Such integrations have recently been noted in isolates from Bangladesh 
(cyaA and yidA sites)15,43 and Zambia (cyaA site)16; however, our data provide important 
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context for these observations, showing that integrations are relatively frequent and have 
been occurring since the emergence of H58. Integration of the MDR locus into the 
chromosome may facilitate loss of the large IncHI1 plasmid, thus moderating any potential 
fitness burden while maintaining the MDR phenotype. A similar phenomenon has been 
observed in Shigella sonnei, where chromosomal integration of an MDR transposon in the 
late 1970s appears to be associated with global dissemination of a single successful 
sublineage44, and in Salmonella that have acquired the Salmonella Genomic Island45. H58 
strains also harbor a higher frequency of quinolone resistance–associated mutations than 
other S. Typhi, potentially owing to enhanced exposure of the large, diversifying and 
frequently MDR H58 population to fluoroquinolones, coupled with the lack of a fitness cost 
associated with these mutations46.
These results provide, to our knowledge, the first global, large-scale, genome-based study of 
an MDR clade of S. Typhi. The global dissemination of H58 requires urgent international 
attention. Indeed, the arrival of S. Typhi H58 in Africa appears to be transforming the 
epidemiology of the disease, with MDR outbreaks of typhoid being reported where the 
disease was previously unappreciated or absent. It will be particularly important to control 
antimicrobial prescribing practices, including the use of prophylactic antibiotics such as 
trimethoprim-sulfamethoxazole47 in this region, as such use likely promotes multidrug 
resistance. This study highlights the need for longstanding routine surveillance to capture 
epidemics and monitor changes in bacterial populations as a means to facilitate public health 
measures, such as the use of effective antimicrobials and the introduction of vaccine 
programs, to reduce the vast and neglected morbidity and mortality caused by typhoid.
URLs. Sprai, http://zombie.cb.k.u-tokyo.ac.jp/sprai/; SMALT, http://www.sanger.ac.uk/
resources/software/smalt/; Path-O-Gen, http://tree.bio.ed.ac.uk/software/pathogen/; Velvet 
Optimizer, http://www.ebi.ac.uk/~zerbino/velvet/; ISmapper, https://github.com/jhawkey/
IS_mapper.
 ONLINE METHODS
 Bacterial isolates and sequencing
A total of 1,832 S. Typhi isolates were included in the study. These were isolated between 
1905 and 2013 and originated from 63 countries spanning 6 continents (Asia, Africa, North 
and South America, Europe, and Australia and Oceania) (Supplementary Table 1). This 
collection included 14 of the 19 S. Typhi isolates previously sequenced by Holt et al.19, 
including the 2 isolates with finished reference genomes, CT18 (AL513382) and Ty2 
(AE014613) (Supplementary Table 2). Seven other public S. Typhi references sequences 
were downloaded from public databases and included in the analysis (Supplementary Table 
2). Information on the source was available for 1,531 of our S. Typhi isolates. The isolates 
included in our study were supplied by numerous contributing laboratories and were 
cultured from a wide range of clinical specimens, including blood (90.9%; 1,391/1,531), 
stool or rectal swab (8.3%; 127/1,531), urine (0.4%; 6/1,531), pus (0.3%; 5/1,531), 
gallbladder fluid (0.1%; 2/1,531), pleural fluid (0.1%; 1/1,531) and cerebrospinal fluid 
(0.1%; 1/1,531). There were data on the age of the patient for 826 S. Typhi isolates, and 
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these comprised 330 (40%) isolates originating from children (0 to ≤16 years old) and 496 
(60%) isolates cultured from adults (>16 years old).
Each of the collaborating laboratories used their own individual methodologies for isolation 
of whole-genomic DNA. For 231 isolates, DNA was prepared using the Wizard Genomic 
DNA kit (Promega) according to the manufacturer’s instructions. Index-tagged paired-end 
Illumina sequencing libraries were prepared as previously described49. These were 
combined into pools each containing 96 uniquely tagged libraries and sequenced on the 
Illumina HiSeq 2000 or HiSeq 2500 platform according to the manufacturer’s protocols to 
generate tagged 100-bp paired-end reads.
In addition, the genomes of five H58 isolates were sequenced on the PacBio RS II platform 
(Pacific Biosciences) for better resolution of the integration of the large composite 
transposable element into the chromosome (Supplementary Table 4). Genomic DNA (3 µg) 
was sheared using the HydroShear Plus (Digilab), and a library was prepared using DNA 
Template Prep Kit 2.0 (Pacific Biosciences), according to the manufacturer’s instructions. 
Sequencing was performed on SMRT cells with XL polymerase and DNA Sequencing Kit 
C2 (Pacific Biosciences). De novo assembly was performed with Sprai v0.9.5 (see URLs) 
and HGAP v2.1.0 (ref. 50) with default parameters. The contigs from Sprai were 
circularized with a script in the Sprai package when the script detected a significant overlap 
between the beginning and end of contigs.
 Read alignment and SNP detection
For analysis of SNPs, paired-end Illumina reads were mapped to the CT18 reference genome 
of S. Typhi, including the chromosome and pHCM1 and pHCM2 plasmids41, using SMALT 
(version 0.7.4) (see URLs) as previously described51,52. Candidate SNPs were identified as 
previously described19,53, using SAMtools command mpileup -d 1000 -DSugBf ref bam > 
results.bcf; bcftools view -cg results.bcf54. SNP calls with quality scores above 30 were 
collated into a single list of variant sites, and the allele at each SNP site in each isolate was 
determined by reference to the consensus base call for that genome (using SAMtools and 
removing low-confidence alleles with consensus base quality <50, SNPs contained in <75% 
of reads and those with mapping quality <30, read depth <4, <2 reads per strand, strand bias 
P < 0.001, mapping bias P < 0.001 or tail bias P < 0.001). SNPs called in phage regions, 
repetitive sequences (354 kb; ~7.4% of bases in the CT18 reference chromosome, as defined 
previously19) or recombinant regions (~180 kb; <4% of the CT18 reference chromosome, 
identified using an approach described previously49) were excluded, resulting in a final set 
of 22,145 chromosomal SNPs identified in an alignment of length 4,275,037 bp.
 Phylogenetic analysis
The maximum-likelihood phylogenetic tree shown in Figure 1b was built from the 22,145-
SNP alignment of all 1,832 isolates, plus a S. Paratyphi A strain included as an outgroup for 
tree rooting, using RAxML (version 7.8.6)55 with the generalized time-reversible model and 
a Gamma distribution to model site-specific rate variation (the GTR+Γ substitution model; 
GTRGAMMA in RAxML). Support for the maximum-likelihood phylogeny was assessed 
via 100 bootstrap pseudoanalyses of the alignment data. A maximum-likelihood 
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phylogenetic tree was also inferred separately from the SNP alignment of 853 H58 S. Typhi 
isolates using the same parameters as above (Fig. 2). The H58 phylogenetic tree was rooted 
using an S. Typhi isolate from the nearest neighboring cluster of non-H58 isolates (isolate 
Fij107364). All maximum-likelihood trees were displayed and annotated using iTOL56,57. 
To simplify visualization of the H58 phylogeny (Fig. 3a), clades containing only isolates 
from a single country were collapsed manually in R. Geographical transitions were inferred 
from this collapsed H58 tree using discrete trait transition modeling, implemented in the 
make.simmap function in the phytools R package. Briefly, each genome was assigned to a 
geographical region on the basis of country of isolation (or presumed region of inoculation 
for travel-associated isolates), these regions were treated as discrete tip states on the H58 
maximum-likelihood tree and a Markov model for the evolution of this state (i.e., 
geographical region) was fitted to the tree, as proposed in ref. 58. Entries in the resulting 
transition matrix were interpreted as likely geographical transfers between regions, drawn as 
arrows on the map in Figure 4 (directionality inferred from visual confirmation of the 
phylogeny).
 Temporal analysis
To investigate temporal signal in the maximum-likelihood phylogeny for S. Typhi, we used 
Path-O-Gen (see URLs) to extract root-to-tip dates and analyzed their linear relationship 
with year of isolation using R. To assess the robustness of the H58 temporal signal, analysis 
of the H58 subtree was repeated 100 times with randomly permuted tip dates. The 
evolutionary dynamics of the H58 lineage were investigated via Bayesian analysis with 
BEAST (v1.6)31. Initial analyses were conducted on 114 isolates from across the H58 
maximum-likelihood tree, covering the full temporal and geographical range of H58. Bias in 
isolate distribution was reduced by selecting a maximum of eight isolates from each 
geographical location, with as much temporal diversity as possible within that location. For 
countries represented by fewer than eight H58 isolates, all isolates at that location were 
included in the BEAST analysis. The concatenated SNP alignments of these 114 isolates 
were subjected to multiple BEAST analyses using both constant population size and 
Bayesian skyline models of changes in population size, in combination with either a strict 
molecular clock or a relaxed clock (uncorrelated lognormal distribution), to identify the 
model that best fitted the data44. For the BEAST analysis, the GTR+Γ substitution model 
was selected, and tip dates were defined as the year of isolation. For all model combinations, 
3 independent chains of 100 million generations each were run to ensure convergence, with 
sampling every 1,000 iterations. The 3 runs were combined with LogCombiner31, following 
removal of the first 10 million steps from each as burn-in. In all cases, the relaxed, 
(uncorrelated lognormal) clock model, which allows evolutionary rates to vary among the 
branches of the tree together with the skyline demographic model, proved a much better fit 
for the data (Bayes factor > 200).
For the final analyses reported here, ten independent runs were conducted with different 
samples of isolates in the alignment but using identical substitution (GTR+Γ), clock 
(uncorrelated, lognormal relaxed) and demographic (Bayesian skyline) models. Each 
permutation contained a different set of randomly selected isolates from India, Pakistan, 
Nepal, Cambodia, Vietnam, Tanzania, Kenya, Laos, Malawi, Bangladesh, Iraq and Fiji. The 
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countries of Sri Lanka, Thailand, South Africa, Afghanistan, Indonesia, Myanmar, Lebanon, 
Palestine and Australia had five or fewer isolates, and all these isolates were therefore 
included in each of the ten permutation data sets. Each set of isolates was subjected to 
triplicate BEAST runs. Maximum–clade credibility (MCC) trees were generated using 
TreeAnnotator31. Estimates reported as median values with 95% HPDs and posterior 
probability values (PPVs) were used as support for the identification of ancestral nodes and 
their associated geographical locations. The Bayesian skyline plot was calculated and 
visualized using Tracer (v1.6), to investigate changes in the effective population size of the 
H58 lineage over time31. The effective sample sizes (ESSs) of the parameters were estimated 
to be >200 for all 10 independent runs of the analysis.
 Gene content analysis
The reads for each isolate were assembled de novo using the short-read assembler Velvet59 
with parameters optimized with Velvet Optimizer (see URLs) to provide the highest N50 
value. Contigs that were less than 300 bp long were excluded from further analysis. The 
assemblies were constructed and annotated using Prokka60 by the Pathogen Informatics 
team at the Wellcome Trust Sanger Institute (Cambridge, UK) using an automated pipeline.
The de novo–assembled contig sets were mapped iteratively to the pan-genome reference set 
(initialized as the concatenation of the S. Typhi CT18 chromosome and plasmids) using 
MUMmer (nucmer algorithm)61 as previously described19. At each iteration stage i, 
sequences not aligning to the current pan-genome Pi – 1 set were incorporated into an 
extended pan-genome, Pi. The final pan-genome P was annotated using both annotation 
transfer (for S. Typhi reference sequences) and de novo annotation with Prokka60. Paired-
end reads were then aligned to the pan-genome using bwa62 with default mapping 
parameters. SAMtools54 was used to produce a pileup for each aligned read set, and this was 
used to summarize, for each annotated gene in the pan-genome P, the coverage (percentage 
of bases covered) and the presence of inactivating mutations (nonsense SNPs or non-triplet 
insertions and/or deletions (indels) resulting in frameshifts) in each genome. The annotated 
pan-genome was specifically examined for the acquisition in H58 of phage sequences and 
plasmids of defined incompatibility groups (see “Plasmid analyses”). New phages identified 
in the pan-genome study were confirmed using analysis of high-quality de novo–assembled 
contigs with the web server PHAST (Phage Search Tool)63.
 Resistance gene analysis
Acquired antimicrobial resistance genes were detected, and their precise alleles were 
determined, using the mapping-based allele typer SRST2 (ref. 64) together with the ARG-
Annot database65. SRST2 was also used to identify mutations in the gyrA, gyrB, parC and 
parE genes that have been associated with resistance in Gram-negative bacteria (including 
Salmonella) to quinolones34,35,66–68. Note, however, that our data were not suitable for 
assessing the presence of azithromycin resistance–related mutations in the 23S rRNA 
sequences, which have been occasionally reported in other bacterial pathogens69–71. The 
horizontal transfer of resistance genes associated with a transposon from the IncHI1 plasmid 
into the chromosome of H58 isolates was analyzed using a combination of the data from the 
Illumina and PacBio sequencing, inspected using a combination of tools, including Genome 
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Browser Artemis and Artemis Comparison Tool (ACT)72, which allowed comparison of the 
genome assemblies against finished sequences for IncHI1 plasmids (pAKU1 (ref. 33) and 
pHCM1 (ref. 41)) and the CT18 chromosome41. IS1 insertion sites were investigated using 
ISmapper (see URLs), which uses bwa62 to map reads to the IS1 sequence and identify those 
reads that flank the IS (defined as those reads that do not map within the IS but whose paired 
reads do). These IS1-flanking reads were then mapped to the CT18 chromosome reference 
sequence, to identify the sites of IS1 insertion in the chromosome.
 Plasmid analyses
Presence of the IncHI1 plasmid was confirmed by (i) BLASTN search of contig sets with 
the sequence of conserved backbone genes (164.1 kb) and antimicrobial resistance genes 
within Tn10 and a composite transposon, Tn2067, generated from comparative analysis of 
the nucleotide sequences of R27 (AF250878), pHCM1 (AL513383) and pAKU1 
(AM412236)33 (Supplementary Table 2) using ACT72, and (ii) detection of an IncHI1 
replicon directly from reads using SRST2 and the PlasmidFinder database (v 1.2)73. IncHI1 
plasmid multilocus sequence typing (MLST) types23 were also determined using SRST2 
(ref. 64). H58 S. Typhi isolates that contained fewer than 38% (63/168) of the backbone 
genes were excluded from further analysis. Additional plasmid replicons were identified 
from the SRST2 analysis of plasmid replicons, and the location of resistance genes was 
determined by manual investigation of the assemblies using BLASTN, Artemis and ACT72.
 H58 SNP repertoire analysis
Nonsynonymous SNPs that were identified in >99% of the H58 isolates and in no other 
lineage were analyzed. The SNPs and their associated genes were studied using Genome 
Browser Artemis72. Functional categories were as annotated in the S. Typhi CT18 genome 
(AL513382.1).
 Statistical methods
Simple, descriptive statistics were used to compare the geographical distributions of 
lineages, prevalence of plasmids, and resistance genes and mutations and to calculate 95% 
confidence intervals. The significance of differences between studied groups of variables 
was calculated using Fisher’s exact test. All statistical tests were two-sided at α = 0.05, and 
analyses were performed using STATA (version 12.1, StataCorp) and R.
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Population structure of the 1,832 S. Typhi isolates analyzed in this study. (a) Temporal 
distribution of the S. Typhi isolates included in the study. (b) Rooted maximum-likelihood 
tree of S. Typhi inferred from 22,145 SNPs, rooted using an outgroup (S. enterica serovar 
Paratyphi A, isolate 9953_5_4_Outgroup_ParatyphiA_IndoA270_2010). The colored ring 
indicates the geographical origin of the isolates. Red arc, H58 lineage; labeled blue dashed 
lines, public reference genomes reported in Holt et al.19, including the CT18 (R) reference 
genome (AL513382); black dashed lines, other publicly available genomes. Branch lengths 
are indicative of the estimated substitution rate per variable site.
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Population structure of the S. Typhi H58 lineage. Rooted maximum-likelihood phylogeny 
inferred from 1,534 SNPs identified in the 853 H58 isolates, rooted using an S. Typhi isolate 
from the nearest neighboring cluster of non-H58 isolates as an outgroup (black filled circle; 
isolate 10060_5_62_ Fij107364_2012). The colored ring indicates the countries of isolation; 
countries discussed in the text are labeled around the tree. Branch lengths are indicative of 
the estimated substitution rate per variable site.
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Geographical persistence and routes for dissemination of S. Typhi H58. (a) Maximum-
likelihood tree for the H58 lineage (I and II), with clades containing isolates from a single 
country collapsed into nodes (circles), sized to indicate the number of isolates in the clade 
and colored by country of isolation. Branches are colored to indicate the country of origin of 
descendant nodes. (b) Years of isolation for each phylogeographical cluster in the tree, 
indicated by lines spanning the earliest and latest years of isolation for each cluster and 
colored to indicate the country. Four regions with extensive local clonal expansion are 
highlighted by shaded boxes, spanning the phylogenetic (y axis) and temporal (x axis) extent 
of the expansion. Locations from which singleton isolates were clustered within the 
phylogeographical clusters are shown to the right, indicative of further onward transmission.
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Major geographical transfers within the H58 lineage, inferred from the phylogenetic tree. 
The size of each arrow indicates the relative number of likely transfers between regions or 
countries.
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Insertion site of the 24-kb composite transposon in CT18. A comparative analysis using 
genoPlotr48 of CT18 and H58 isolates ERL12960 (ERR343327) and 12148 (ERR343322) 
showed two integration sites of the transposon in the chromosome. The nucleotide sequence 
of the composite transposon was identical to that in the IncHI1-PST6 plasmid of H58 isolate 
10425_1_48_Viety3-193_1997, which was sequenced for comparison. Tn, transposon; TSD, 
target site duplication.
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Acquired multidrug resistance in the S. Typhi H58 lineage. Maximum-likelihood phylogeny 
from 1,534 SNPs of 853 H58 isolates rooted using an S. Typhi isolate from the nearest 
neighboring cluster of non-H58 isolates as an outgroup (isolate 10060_5_62_ 
Fij107364_2012) and surrounded by five colored rings representing (1) geographical origin 
in terms of region, (2) number of transposon-encoded resistance genes, (3) presence of 
resistance plasmids, (4) presence of IS1 insertion near the cyaA gene and (5) the site of 
chromosomal integration. Black radial dashed lines show the positions of public reference 
strains. Branch lengths are indicative of the estimated substitution rate per variable site.
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